sanofi-gsk

Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India

Sanofi and GSK received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity…

3 years ago

NICE turns down GSK’s IV Benlysta for systemic lupus

The National Institute for Health and Care Excellence (NICE) has rejected NHS funding for an intravenous formulation of GlaxoSmithKline's Benlysta…

3 years ago

Sanofi partners with BIG, EORTC, AFT to study amcenestrant for ER+ breast cancer treatment

Sanofi is partnering with the Breast International Group (BIG), the European Organization for Research and Treatment of Cancer (EORTC) and…

3 years ago

After setback, Sanofi-GSK reports success in COVID-19 vaccine

Sanofi and GlaxoSmithKline’s potential COVID-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials after an…

3 years ago